[1] J.P. Arcede, R.L. Caga-Anan, C.Q. Mentuda, Y. Mammeri, Accounting for symptomatic and asymptomatic in a SEIR-type model of COVID-19, Math. Model. Nat. Phenom. 15 (2020) 34.
[2] L. Basnarkov, SEAIR epidemic spreading model of COVID-19, Chaos Solitons Fract. 142 (2021) 110394.
[3] F. Brauer, C. Castillo-Chavez, Mathematical Models in Population Biology and Epidemiology, Springer, 2012.
[4] L.E. Brümmer, S. Katzenschlager, M. Gaeddert, C. Erdmann, S. Schmitz, M. Bota, M. Grilli, J. Larmann, M.A. Weigand, N.R. Pollock, Diagnostic accuracy of rapid antigen tests in symptomatic and asymptomatic SARS-CoV-2 infections, PLoS Med. 20 (2023) e1004108.
[5] N. Cangiotti, M. Capolli, M. Sensi, S. Sottile, A survey on Lyapunov functions for epidemic compartmental models, Boll. Unione Mat. Ital. 17 (2024) 241–257.
[6] C. Castillo-Chavez, B. Song, Dynamical models of tuberculosis and their applications, Math. Biosci. Eng. 1 (2004) 361–404.
[7] C. Cohen, J. Kleynhans, J. Moyes, M.L. McMorrow, F.K. Treurnicht, O. Hellferscee, A. Mathunjwa, A. von Gottberg, N. Wolter, N.A. Martinson, Asymptomatic transmission and high community burden of seasonal influenza in South Africa, Lancet Glob. Health 9 (2021) e863–e874.
[8] K.L. Cooke, Functional-differential equations: some models and perturbation problems, Differential Equations and Dynamical Systems, Proc. Int. Symp., Univ. of Puerto Rico (1967) 27–30.
[9] M.C. Gómez, E. Ibargüen Mondragón, Global stability analysis for a SEI model with nonlinear incidence rate and asymptomatic infectious state, Appl. Math. Comput. 402 (2021) 126130.
[10] J.A.P. Heesterbeek, A brief history of R0 and a recipe for its calculation, Acta Biotheor. 50 (2002) 189–204.
[11] Z. Hu, C. Song, C. Xu, Clinical characteristics of 24 asymptomatic infections with COVID-19, Infect. Dis. Poverty 9 (2020) 1–9.
[12] S.-B. Hsu, Y.-H. Hsieh, On the role of asymptomatic infection in transmission dynamics of infectious diseases, Bull. Math. Biol. 70 (2008) 134–155.
[13] S. Kadyrov, Y. Aitzhanov, Z.I. Muminov, Global stability analysis of a novel epidemic model with separate compartments for symptomatic and asymptomatic cases, Lobachevskii J. Math. 46 (2025) 683–696.
[14] W.O. Kermack, A.G. McKendrick, G.T. Walker, A contribution to the mathematical theory of epidemics, Proc. Roy. Soc. Lond. Ser. A 115 (1927) 700–721.
[15] W.O. Kermack, A.G. McKendrick, G.T. Walker, Contributions to the mathematical theory of epidemics. II — The problem of endemicity, Proc. Roy. Soc. Lond. Ser. A 138 (1932) 55–83.
[16] W.O. Kermack, A.G. McKendrick, G.T. Walker, Contributions to the mathematical theory of epidemics. III — Further studies of the problem of endemicity, Proc. Roy. Soc. Lond. Ser. A 141 (1933) 94–122.
[17] S. Lamei, Dynamical behavior of a multi-group stochastic SEIR system with symptomatic and asymptomatic individuals, J. Math. Model. 13 (2025) 767–786.
[18] J. La Salle, S. Lefschetz, Stability by Liapunov's Direct Method, Academic Press, 1961.
[19] T.W. Leulseged, D.G. Alemahu, I.S. Hassen, E.H. Maru, W.C. Zewde, N.W. Chamiso, K.T. Yegele, D.S. Abebe, F.M. Abdi, E.Y. Minyelshewa, T.G. Gerbi, H.T. Hagos, Factors associated with development of symptomatic disease in Ethiopian COVID-19 patients, BMC Infect. Dis. 21 (2021) 759.
[20] Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, R. Ren, K.S.M. Leung, E.H.Y. Lau, J.Y. Wong, Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia, N. Engl. J. Med. 382 (2020) 1199–1207.
[21] Z. Liu, T. Zhou, Analysis of global stability of an epidemic model with asymptomatic infected persons, Adv. Contin. Discrete Models 2025 (2025) 85.
[22] J. Pan, Z. Chen, Y. He, T. Liu, X. Cheng, J. Xiao, H. Feng, Why controlling the asymptomatic infection is important: A modelling study with stability and sensitivity analysis, Fractal Fract. 6 (2022) 197.
[23] S.Y. Park, Y.-M. Kim, S. Yi, S. Lee, B.-J. Na, C.B. Kim, J.-I. Kim, H.S. Kim, Y.B. Kim, Y. Park, Coronavirus disease outbreak in call center, South Korea, Emerg. Infect. Dis. 26 (2020) 1666.
[24] E. Schuit, C. Vilaplana, J. Dinnes, J.J. Deeks, J. Domen, A. Lentferink, P. Olliaro, A. van den Bruel, L. Hooft, P.M. Bossuyt, Serial self-testing using antigen rapid diagnostic tests in symptomatic and asymptomatic SARS-CoV-2 infections, Lancet Microbe 4 (2023) e623–e633.
[25] Z. Shuai, Global stability of infectious disease models using Lyapunov functions, SIAM J. Appl. Math. 73 (2013) 1513–1532.
[26] M.W. Tenforde, Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network, MMWR Morb. Mortal. Wkly. Rep. 69 (2020).
[27] N. van der Moeren, G. Zwart, E. Lodder, H. van Esch, J. Stohr, B.B. Oude Munnink, A.A. van der Eijk, R. Molenkamp, S.D. Pas, M.P. Koopmans, Performance evaluation of the BD Veritor SARS-CoV-2 antigen rapid test, Clin. Microbiol. Infect. 28 (2022) 1266–1272.
[28] J. Watmough, Role of incidence function in vaccine-induced backward bifurcation in some HIV models, Math. Biosci. 210 (2007) 436–463.
[29] J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Math. Biosci. 180 (2002) 29–48.
[30] World Health Organization, Novel Coronavirus (2019-nCoV) Situation Report–142, WHO, 2020.
[31] World Health Organization, Crude Birth Rate (births per 1000 population), WHO, 2020.
[32] M. Yanes-Lane, N. Winters, F. Fregonese, M. Bastos, S. Perlman-Arrow, J.R. Campbell, D. Menzies, Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential, PLOS One 15 (2020) e0241536.
[33] P. Zhang, Q. Zhang, X. Wei, Q. Cui, Modeling and analysis of a class of epidemic models with asymptomatic infection and transmission heterogeneity, J. Appl. Math. Comput. (2025) 1–28.
[34] C.Q. Zhu, S.D. Gao, Y. Xu, X.H. Yang, F.Q. Ye, L.L. Ai, R.C. Lv, B. Zhang, Y. Li, H. Lv, A COVID-19 case report from asymptomatic contact, Infect. Dis. Poverty 9 (2020) 70.